Barney Balmforth On Raising $60 Million To Build A Genomic Technology Platform For Genome Testing And Cancer Diagnostics
Barney Balmforth's journey is a testament to calculated risk-taking, resilience, visionary leadership, and two pivotal lessons: the importance of taking calculated risks and pursuing meaningful endeavors. These values, along with the inspiration to work hard, drove Barney's career in the high-stakes world of tech and biotech startups. His latest startup, Biofidelity, has attracted funding from top-tier investors like Agilent Technologies, Octopus Ventures, BlueYard Capital, and SBI Investment.
DealMakers: Entrepreneur | Startups | Venture Capital
Audio is streamed directly from the publisher (injector.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Barney Balmforth's journey is a testament to calculated risk-taking, resilience, visionary leadership, and two pivotal lessons: the importance of taking calculated risks and pursuing meaningful endeavors. These values, along with the inspiration to work hard, drove Barney's career in the high-stakes world of tech and biotech startups. His latest startup, Biofidelity, has attracted funding from top-tier investors like Agilent Technologies, Octopus Ventures, BlueYard Capital, and SBI Investment.